Xueqian Yin

Mayo Clinic

Papers

1

Total Citations

16

H-Index

1

About

Xueqian Yin is a surgical oncologist and clinical researcher whose work focuses on the intersection of transoral robotic surgery (TORS) and de-escalation strategies for HPV-associated oropharyngeal squamous cell carcinoma. Her major contribution lies in demonstrating that carefully selected patients can achieve excellent oncologic outcomes with reduced treatment intensity, thereby minimizing long-term toxicity. In her landmark 2023 study, which analyzed data from two prospective adjuvant de-escalation trials (MC1273 and MC1675), she reported 30-day morbidity and mortality outcomes after TORS, providing critical safety benchmarks for this approach. With 16 citations, this work has already influenced clinical decision-making in head and neck oncology. Yin’s research is notable for its pragmatic, patient-centered focus—balancing cancer control with quality of life—and her findings support the growing paradigm shift toward less aggressive, yet equally effective, treatment protocols. Her ongoing investigations continue to refine risk stratification and surgical techniques, positioning her as a rising voice in the effort to personalize therapy for HPV-positive oropharyngeal cancer patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675)
16 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Mayo Clinic

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago